Chapel H: Classification of primary immunodeficiency diseases by the International Union of Immunological Societies (IUIS) expert committee on primary immunodeficiency 2011. Clin Exp Immunol. 2012, 168 (1): 58-59. 10.1111/j.1365-2249.2012.04561.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Griscelli C, Fischer A, Grospierre B, Durandy A, Bremard C, Charron D, Vilmer E, Virelizier J-L: Clinical and immunological aspects of combined immunodeficiency with defective expression of HLA antigens. 1984, Amsterdam: Excerpta Medica
Google Scholar
Griscelli C, Lisowska-Grospierre B, Mach B: Combined immunodeficiency with defective expression in MHC class II genes. Immunodeficiencies. Edited by: Rosen FS, Seligman M. 1993, Chur, Switzerland: Harwood Academic, 141-
Google Scholar
Durand B, Sperisen P, Emery P: RFXAP, a novel subunit of the RFX DNA binding complex, is mutated in MHC class II deficiency. EMBO J. 1997, 16: 1045-1055. 10.1093/emboj/16.5.1045.
Article
PubMed Central
CAS
PubMed
Google Scholar
Masternak K, Barras E, Zufferey M: A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat Genet. 1998, 20: 273-277. 10.1038/3081.
Article
CAS
PubMed
Google Scholar
Steimle V, Durand B, Barras E: A novel DNA binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 1995, 9: 1021-1032. 10.1101/gad.9.9.1021.
Article
CAS
PubMed
Google Scholar
Steimle V, Otten LA, Zufferey M, Mach B: Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 1993, 75: 135-146.
Article
CAS
PubMed
Google Scholar
Fondaneche MC, Villard J, Wiszniewski W: Genetic and molecular definition of complementation group D in MHC class II deficiency. Hum Mol Genet. 1998, 7: 879-885. 10.1093/hmg/7.5.879.
Article
CAS
PubMed
Google Scholar
Hume CR, Lee JS: Congenital immunodeficiency associated with absence of HLA class II antigens on lymphocyte result from distinct mutations in transacting factors. Hum Immunol. 1989, 26: 288-309. 10.1016/0198-8859(89)90007-4.
Article
CAS
PubMed
Google Scholar
Krawczyk M, Reith W: Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease. J Compilation. 2006, 67: 183-197.
CAS
Google Scholar
Lisowska-Grospierre B, Fondaneche MC, Rols MP: Two complementation groups accent for most cases of inherited MHC class II deficiency. Hum Mol Genet. 1994, 3: 953-958. 10.1093/hmg/3.6.953.
Article
CAS
PubMed
Google Scholar
Reith W, Satola S, Sanchez CH: Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell. 1988, 53: 897-906. 10.1016/S0092-8674(88)90389-3.
Article
CAS
PubMed
Google Scholar
Masternak K, Muhlethaler-Mottet A, Villard J: CIITA is a transcriptional coactivator that is recruited to MHC II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 2000, 14: 1156-1166.
PubMed Central
CAS
PubMed
Google Scholar
Steimle V, Siegrist CA, Mottet A: Regulation of MHC class II expression by interferon mediated by the transactivator gene CIITA. Science. 1994, 265: 106-109. 10.1126/science.8016643.
Article
CAS
PubMed
Google Scholar
Klein C, Lisowska-Grospierre B, Ledeist F: Major histocompatibility complex class II deficiency: clinical manifestations, immunological features and outcome. J Pediatr. 1993, 123 (6): 921-928. 10.1016/S0022-3476(05)80388-9.
Article
CAS
PubMed
Google Scholar
Ouederni M, Vincent QB, Frange P: Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood. 2011, 118 (19): 5108-5118. 10.1182/blood-2011-05-352716.
Article
CAS
PubMed
Google Scholar
Report of an IUIS Scientific Group: Primary immunodeficiency diseases. Clin Exp Immunol. 1999, 118 (suppl 1): 1-28.
Google Scholar
Wiszniewski W, Fondaneche MC, Lambert N: Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II deficient patients belonging to complementation group B. Immunogenetics. 2000, 51: 261-267. 10.1007/s002510050619.
Article
CAS
PubMed
Google Scholar
Nagarajan UM, Louis-Plence P, DeSandro A: RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity. 1999, 10: 153-162. 10.1016/S1074-7613(00)80016-3.
Article
CAS
PubMed
Google Scholar
Shearer WT, Rosenblatt HM, Gelman RS: Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003, 112 (5): 973-980. 10.1016/j.jaci.2003.07.003.
Article
PubMed
Google Scholar
Griscelli C: Combined immunodeficiency with defective expression in MHC class II genes. Clin Immunol Immunopathol. 1991, 61: 106-110. 10.1016/S0090-1229(05)80045-5.
Article
Google Scholar
Bejaoui M, Barbouche MR, Dellagi K: Les déficits immunitaires primitifs en Tunisie; étude de 152 cas. Arch Pediatr. 1997, 4: 827-831. 10.1016/S0929-693X(97)88145-6.
Article
CAS
PubMed
Google Scholar
Benallegue M, Kedjif F: Consanguinité et santé publique, étude algérienne. Arch Fr Pédiatr. 1984, 41: 435-440.
CAS
PubMed
Google Scholar
Bousfiha AA, Ailal F, Picard C: Epidémiologie et classification des déficits immunitaires primitifs. Rev Mar Mal Enf. 2008, 18: 5-11.
Google Scholar
Lamdaouer Bouazzaoui N: Consanguinité et Santé publique au Maroc. Bull Acad Natl Med. 1994, 178: 1013-1027.
Google Scholar
Griscelli C, Lisowska-Grospierre B, Le Deist F: Combined immunodeficiency with abnormal expression of MHC class II genes. Clin Immunol Immunopathol. 1989, 50: S140-S148. 10.1016/0090-1229(89)90121-9.
Article
CAS
PubMed
Google Scholar
Bejaoui M, Barbouche MR, Mellouli F: Déficit immunitaire primitif par défaut d’expression des antigènes de classe II: neuf observations tunisiennes. Arch Pediatr. 1998, 5: 1089-1093. 10.1016/S0929-693X(99)80005-0.
Article
CAS
PubMed
Google Scholar
Saleem MA, Arkwright PD, Davies EG: Clinical course of patients with major histocompatibility complex class II deficiency. Arch Dis Child. 2000, 83: 356-359. 10.1136/adc.83.4.356.
Article
PubMed Central
CAS
PubMed
Google Scholar
Nekrep N, Geyer M, Jabrane-Ferrat N, Peterlin BM: Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome. Mol Cell Biol. 2001, 21: 5566-5576. 10.1128/MCB.21.16.5566-5576.2001.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lennon-Dumenil AM, Barbouche MR, Vedrenne J: Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHC class II deficiency. J Immunol. 2001, 166: 5681-5687.
Article
CAS
PubMed
Google Scholar
Nagarajan UM, Peijnenburg A, Gobin SJ: Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-Bdeficient cells. J Immunol. 2000, 164: 3666-3674.
Article
CAS
PubMed
Google Scholar
Prod'homme T, Dekel B, Barbieri G: Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course. Immunogenetics. 2003, 55: 530-539. 10.1007/s00251-003-0609-2.
Article
PubMed
Google Scholar
Wiszniewski W, Fondaneche MC, Louise-Plence P: Novel mutations in the RFXANK gene: RFX complex containing in vitro-generated RFXANK mutant binds the promoter without transactivating MHC II. Immunogenetics. 2003, 54: 747-755.
CAS
PubMed
Google Scholar
Naamane H, El Maataoui O, Ailal F: The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population. Eur J Pediatr. 2010
Google Scholar
Wiszniewski W, Fondaneche MC, Le Deist F: Mutation in the class II trans-activator leading to a mild immunodeficiency. J Immunol. 2001, 167: 1787-1794.
Article
CAS
PubMed
Google Scholar